Site Map - CML Alliance | Novartis Oncology

For Healthcare Professionals Outside the US

Access educational resources for your patients to help them better understand and manage their CML.
Learn more >

Since its development, Glivec^® has been a cornerstone of therapy for CML patients.
Learn more >

Treating CML

Targeting Bcr-Abl in CML
CML Treatment Goals
Glivec® Side Effects Management

Targeted Therapies and CML

Importance of Targeted Therapies in Cancer

Monitoring Treatment & Response

Monitoring Molecular Response
PCR Testing: Setting the Standards
Guidelines & Recommendations

CML Resources

Patient Education
Guidelines & Recommendations

CML Clinical Trials

CML Clinical Trials in Tasigna®
CML Clinical Trials in Glivec®
Links to Information

Novartis' Commitment to the Global CML Community

Leading Scientific Discovery

See European Summary of Product Characteristics

Glivec® 100 mg film coated tablets (PDF)

Glivec® 400 mg film coated tablets (PDF)

Glivec® 50 mg capsules, hard (PDF)

Glivec® 100 mg capsules, hard (PDF)

Contact | Site Map | Privacy
Use of this website is subject to our Terms of Use

Disclaimer: This site is intended to provide information to healthcare professionals outside the United States. Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local Novartis company for local prescribing and any other information you may be interested in.